All the key equity indexes are up 16% or more this year, as earnings season starts.
Company founders often treat their firms like personal empires even after businesses go public.
There are plenty of negatives out there right now, but the price action still indicates some underlying optimism.
Here are five key stories to know about.
I am neutral on this market, and only a cool off of the hottest stocks can justify a further advance.
Investors should keep tabs on these "focus events" from this quartet of U.S.-listed Japanese drugmakers that can make or break their treatments.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.